These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 33211084)
21. Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation. Ahn MS; Yoo BS; Yoon J; Lee SH; Kim JY; Ahn SG; Youn YJ; Lee JW; Son JW; Kim HS; Kang DR; Cho HJ; Lee HY; Jeon ES; Kang SM; Choi DJ; Cho MC Heart; 2020 Feb; 106(4):292-298. PubMed ID: 31492703 [TBL] [Abstract][Full Text] [Related]
22. [Chronic heart failure : current guideline recommendations and innovations]. Ewen S; Mahfoud F; Böhm M Internist (Berl); 2015 Jul; 56(7):791-802. PubMed ID: 26088170 [TBL] [Abstract][Full Text] [Related]
23. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Schulz M; Griese-Mammen N; Anker SD; Koehler F; Ihle P; Ruckes C; Schumacher PM; Trenk D; Böhm M; Laufs U; Eur J Heart Fail; 2019 Aug; 21(8):1012-1021. PubMed ID: 31129917 [TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333 [TBL] [Abstract][Full Text] [Related]
28. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Gayat E; Arrigo M; Littnerova S; Sato N; Parenica J; Ishihara S; Spinar J; Müller C; Harjola VP; Lassus J; Miró Ò; Maggioni AP; AlHabib KF; Choi DJ; Park JJ; Zhang Y; Zhang J; Januzzi JL; Kajimoto K; Cohen-Solal A; Mebazaa A; Eur J Heart Fail; 2018 Feb; 20(2):345-354. PubMed ID: 28849606 [TBL] [Abstract][Full Text] [Related]
29. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis. Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis. Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582 [TBL] [Abstract][Full Text] [Related]
31. Heart failure clinics improve use of evidence-based heart failure therapies in patients with reduced ejection fraction following acute coronary syndrome (ANZACS-QI 48). Chan D; Doughty RN; Mazengarb J; McLachlan A; Kerr AJ N Z Med J; 2020 Jun; 133(1516):58-71. PubMed ID: 32525862 [TBL] [Abstract][Full Text] [Related]
32. Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction. Pitt B; Rossignol P Clin Pharmacol Ther; 2017 Sep; 102(3):389-391. PubMed ID: 28707341 [TBL] [Abstract][Full Text] [Related]
33. [Update on therapy of chronic heart failure. Innovations and studies from last year]. Ewen S; Linicus Y; Böhm M Herz; 2015 Dec; 40(8):1084-9. PubMed ID: 26135467 [TBL] [Abstract][Full Text] [Related]
34. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978 [TBL] [Abstract][Full Text] [Related]
35. Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature. Bots SH; Groepenhoff F; Eikendal ALM; Tannenbaum C; Rochon PA; Regitz-Zagrosek V; Miller VM; Day D; Asselbergs FW; den Ruijter HM JACC Heart Fail; 2019 Mar; 7(3):258-266. PubMed ID: 30819382 [TBL] [Abstract][Full Text] [Related]
36. Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part II. McIlvennan CK; Page RL J Cardiovasc Nurs; 2016; 31(6):545-554. PubMed ID: 27028591 [TBL] [Abstract][Full Text] [Related]
37. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments. Naegele M; Flammer AJ; Enseleit F; Ruschitzka F Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014 [TBL] [Abstract][Full Text] [Related]
38. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction. Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362 [TBL] [Abstract][Full Text] [Related]
39. Guideline-Directed Medical Therapy Clinics: A Call to Action for the Heart Failure Team. O'Connor CM JACC Heart Fail; 2019 May; 7(5):442-443. PubMed ID: 31047024 [No Abstract] [Full Text] [Related]
40. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions? Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]